Liver cancer in India is rising in tandem with hepatitis B/C and the increasing burden of NAFLD/NASH. Surveillance ultrasound and AFP every six months in cirrhotic patients catches small, potentially curable tumours. Treatment is staged by tumour size, number, vascular invasion, and underlying liver function (Child-Pugh, MELD). Surgical resection is offered when the tumour is anatomically resectable and the patient has adequate functional liver reserve.